期刊文献+

HBx和mIL-12双基因重组腺病毒的构建

Construction of Recombinant Adenovirus Carrying HBx and mIL-12
原文传递
导出
摘要 目的构建携带双基因HBx和mIL-12的重组腺病毒Ad-HBx-mIL-12。方法采用酶切、连接的方法分别将基因HBx和mIL-12连接到穿梭质粒载体pAdenoVator-CMV5。将构建正确的穿梭质粒pAdV-HBx-mIL-12经EcoRⅠ酶切线性化后,转化于含腺病毒骨架质粒pAdenoVatorΔE1/E3的BJ5183感受态细菌,实现细菌内同源重组。将鉴定正确的重组腺病毒质粒pAd-HBx-mIL-12经PacⅠ酶切线性化后,以脂质体法转染至293细胞,包装并扩增获得携带双基因HBx和mIL-12的重组腺病毒Ad-HBx-mIL-12。结果经鉴定携带HBx和mIL-12双基因的重组腺病毒构建成功,并可在293细胞中有效表达。结论成功构建了携带双基因HBx和mIL-12的重组腺病毒Ad-HBx-mIL-12,为探讨其联合抗肿瘤机制及后续基因治疗奠定了基础。 Objective To construct a recombinant adenovirus Ad-HBx-mIL-12 carrying HBx and mIL-12. Methods HBx and mIL-12 were cloned into the shuttle plasmid pAdenoVator-CMV5 and confirmed by means of enzymatic manipulation. After linearization by EcoR Ⅰ digestion, the recombinant shuttle plasmid pAdV-HBx-mIL- 12 was transformed into competent BJ5183 germs with the adenoviral backbone plasmid pAdenoVator AE1/E3 and then homologically recombined to obtain the recombinant adenovirus plasmid. After confirmation, the recombinant adenovirus plasmid pAd-HBx-mIL-12 was linearized with Pac Ⅰ digestion and transfected into 293 cells via liposome, and then adenovirus package and amplification were performed. Results It was confirmed that the recombinant adenovirus Ad-HBx-mIL-12 had been successfully constructed and both HBx and raiL-12 were expressed in 293 cells. Conclusion The recombinant adenovirus carrying HBx and mIL-12 has been successfully constructed, which lays a foundation for the further study of antitumor mechanism and gene therapy.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2010年第6期936-940,共5页 Journal of Sichuan University(Medical Sciences)
基金 国家863计划(编号2006AA022488) 国家自然科学基金(批准号30973452)资助
关键词 HBX mIL-12重组腺病毒基因治疗 HBx mIL-12 Recombinant adenovirus Gene therapy
  • 相关文献

参考文献16

  • 1Murakani S. Hepatitis B virus X proteins structure, function and biology. Intervirology,1999;42(2-3):81-99.
  • 2Michele D, Emilio B, Stefania C, et al. Interleukin-12: biological properties and clinical application. Ciin Cancer Res, 2007 ; 13 (1-) : 4677-4685.
  • 3Sangro B, Melero I, Qian C, et al. Gene therapy of cancer based on interleukin 12. Current Gene Therapy, 2005 , 5 (6):573-581.
  • 4Mulherkav R. Gene therapy for cancer. Curr Sei India, 2001, 81(5) :555-580.
  • 5He TC, Zhou S, Costa LT, et al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A, 1998 ,95 (5) : 2509-2514.
  • 6Stec DE, Morimoto S, Sigmund CD, et al. AdEasy system made easier by selecting the viral backbone plasmid preceding homologous recombination. Biotechniques, 2001,31(2): 260- 262.
  • 7Luo JY, Deng ZL, Luo XJ, et al. A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nature Protocols, 2007, 2 (5) : 1236-1247.
  • 8Zhang WW, Fang X, Branch CD, et al. Generation and identification of recombinant adenovirus by liposome-mediated transfection and PCR analysis. Biofeedback, 1993 , 15 (5) : 868- 871.
  • 9Putzer BM, Hitt M, Muller WJ, et al. Interleukin 12 and B7-1 costimulatory molecule expressed by anadenovirus vector act synergistically to facilitate tumor regression. Proc Natl Acad Sci U S A,1997;94(20):10889-10894.
  • 10Wang Z, Qiu SJ, Ye SL, et al. Combined IL-12 and GM-CSF gene therapy for murine hepatoeellular carcinoma. Cancer Gene Ther,2001,8(10) :751-758.

二级参考文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部